نتائج البحث - "Fernando De Vita"

المساهمون: Brunetti, O., Luchini, C., Argentiero, A., Tommasi, S., Mangia, A., Aprile, G., Marchetti, P., Vasile, E., Casadei Gardini, A., Scartozzi, M., Barni, S., Delfanti, S., De Vita, F., Di Costanzo, F., Milella, M., Cella, C. A., Berardi, R., Cataldo, I., Santini, D., Doglioni, C., Maiello, E., Lawlor, R. T., Mazzaferro, V., Lonardi, S., Giuliante, F., Brandi, G., Scarpa, A., Cascinu, S., Silvestris, N., Brunetti O., Luchini C., Argentiero A., Tommasi S., Mangia A., Aprile G., Marchetti P., Vasile E., Casadei Gardini A., Scartozzi M., Barni S., Delfanti S., De Vita F., Di Costanzo F., Milella M., Cella C.A., Berardi R., Cataldo I., Santini D., Doglioni C., Maiello E., Lawlor R.T., Mazzaferro V., Lonardi S., Giuliante F., Brandi G., Scarpa A., Cascinu S., Silvestris N.

المصدر: Tumori Journal. 105:353-358

مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Pancreatic ductal adenocarcinoma, Adenosquamous carcinoma, pancreatic cancer, Acinar Cell, Carcinoma, Adenosquamou, chemotherapy, Gastroenterology, Carcinoma, Adenosquamous, Adenosquamous, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Pancreatic cancer, Carcinosarcoma, medicine, Humans, Anaplastic carcinoma, Retrospective Studies, Rare tumors, Carcinoma, Acinar Cell, business.industry, Rare tumor, Carcinoma, Pancreatic Neoplasm, General Medicine, medicine.disease, Immunohistochemistry, Cystic Neoplasm, Pancreatic Neoplasms, 030104 developmental biology, Italy, Oncology, Pancreatic exocrine cancer, Medullary carcinoma, Pancreatic Ductal, 030220 oncology & carcinogenesis, biomolecular characterization, Female, Carcinoma, Pancreatic Ductal, business, Human

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27420ac94dc090b51f04410ea0a74f29Test
https://doi.org/10.1177/0300891619839461Test

4

دورية أكاديمية

“Oxaliplatin plus high dose folinic acid and 5-fluoruracil i.v. bolus (OXAFAFU) versus irinotecan plus high dose folinic acid and 5-fluoruracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: Southern Italy Cooperative Oncology Group trial 0103”

المؤلفون: PASQUALE COMELLA, BRUNO MASSIDDA, GIANFRANCO FILIPPELLI, DONATO NATALE, ANTONIO FARRIS, FERNANDO DE VITA, FRANCO BUZZI, SALVATORE TAFUTO, LUIGI MAIORINO, SERGIO MANCARELLA, SILVANA LEO, VITO LORUSSO, LUIGI DE LUCIA, MARIO ROSELLI, PALMERI, Sergio

المساهمون: PASQUALE COMELLA, BRUNO MASSIDDA, GIANFRANCO FILIPPELLI, PALMERI S, DONATO NATALE, ANTONIO FARRIS, FERNANDO DE VITA, FRANCO BUZZI, SALVATORE TAFUTO, LUIGI MAIORINO, SERGIO MANCARELLA, SILVANA LEO, VITO LORUSSO, LUIGI DE LUCIA, MARIO ROSELLI

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/15837702; info:eu-repo/semantics/altIdentifier/wos/WOS:000229867900005; volume:16 (6); firstpage:878; lastpage:886; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/10447/18538Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-21344459245

الإتاحة: http://hdl.handle.net/10447/18538Test

View record in BASE

5

Gastric cancer: Translating novels concepts into clinical practice

المؤلفون: Massimiliano, Salati, Giulia, Orsi, Elisabeth, Smyth, Giuseppe, Aprile, Giordano, Beretta, Fernando, De Vita, Maria, Di Bartolomeo, Valentina, Fanotto, Sara, Lonardi, Federica, Morano, Filippo, Pietrantonio, Carmine, Pinto, Lorenza, Rimassa, Enrico, Vasile, Caterina, Vivaldi, Alberto, Zaniboni, Pina, Ziranu, Stefano, Cascinu

المساهمون: Salati, M., Orsi, G., Smyth, E., Beretta, G., De Vita, F., Di Bartolomeo, M., Fanotto, V., Lonardi, S., Morano, F., Pietrantonio, F., Pinto, C., Rimassa, L., Vasile, E., Vivaldi, C., Zaniboni, A., Ziranu, P., Cascinu, S.

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Biomarkers, Gastric cancer, Genomic tumour profiling, Immunotherapy, Liquid biopsy, Targeted therapy, Animals, Clinical Trials as Topic, Disease Management, Drug Therapy, Combination, Humans, Precision Medicine, Stomach Neoplasms, Translational Research, Biomedical, Treatment Outcome, Biomedical, medicine.medical_treatment, 03 medical and health sciences, 0302 clinical medicine, Drug Therapy, Stomach Neoplasm, Translational Research, medicine, Radiology, Nuclear Medicine and imaging, In patient, Disease management (health), Intensive care medicine, Translational Medical Research, Animal, business.industry, Cancer, Combination chemotherapy, Biomarker, General Medicine, Precision medicine, medicine.disease, Supportive interventions, Clinical Practice, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Combination, business, Human

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a00c6ff065285c8ffb93642d6b36f073Test
http://hdl.handle.net/11568/1114502Test

6

Systemic Chemotherapy for Advanced Rare Pancreatic Histotype Tumors: A Retrospective Multicenter Analysis

المساهمون: Brunetti, Oronzo, Aprile, Giuseppe, Marchetti, Paolo, Vasile, Enrico, Casadei Gardini, Andrea, Scartozzi, Mario, Barni, Sandro, Delfanti, Sara, De Vita, Fernando, Di Costanzo, Francesco, Milella, Michele, Cella, Chiara Alessandra, Berardi, Rossana, Cataldo, Ivana, Scarpa, Aldo, Basile, Debora, Mazzuca, Federica, Graziano, Giusi, Argentiero, Antonella, Santini, Daniele, Reni, Michele, Cascinu, Stefano, Silvestris, Nicola

المصدر: Pancreas. 47(6)

مصطلحات موضوعية: Oncology, mucinous cystadenocarcinoma, Endocrinology, Diabetes and Metabolism, Acinar Cell, Kaplan-Meier Estimate, Cystadenocarcinoma, Mucinous, 0302 clinical medicine, Endocrinology, Antineoplastic Combined Chemotherapy Protocols, Mucinous, Cystadenocarcinoma, pancreatic acinar cell cancer, Middle Aged, Prognosis, Adenocarcinoma, Mucinous, Aged, Carcinoma, Acinar Cell, Carcinoma, Adenosquamous, Carcinoma, Pancreatic Ductal, Humans, Pancreatic Neoplasms, Retrospective Studies, Treatment Outcome, Diabetes and Metabolism, Pancreatic Ductal, pancreatic adenosquamous cancer, rare pancreatic tumor, Internal Medicine, Hepatology, 030220 oncology & carcinogenesis, Exocrine pancreatic cancer, Adenocarcinoma, 030211 gastroenterology & hepatology, Mucinous cystadenocarcinoma, medicine.medical_specialty, pancreatic ductal adenocarcinoma, Adenosquamous, 03 medical and health sciences, Internal medicine, medicine, Acinar cell, Carcinoma, business.industry, Cancer, medicine.disease, Cystic Neoplasm, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9ea8736bdbc7595a60cdeee7d0f734dTest
https://pubmed.ncbi.nlm.nih.gov/29771769Test

7

Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma

المؤلفون: M.A. Porricelli, Massimiliano Berretta, Carmine D'Aniello, Sabrina Rossetti, Carla Cavaliere, Fernando De Vita, Gelsomina Iovane, Salvatore Pisconti, Sarah Scagliarini, Maria Maddalena Laterza, Clementina Savastano, Giacomo Cartenì, Gaetano Facchini

المساهمون: Rossetti, Sabrina, D'Aniello, Carmine, Iovane, Gelsomina, Scagliarini, Sarah, Laterza, Maria M., De Vita, Fernando, Savastano, Clementina, Cartenì, Giacomo, Porricelli, Maria A., Berretta, Massimiliano, Pisconti, Salvatore, Facchini, Gaetano, Cavaliere, Carla

المصدر: Frontiers in Pharmacology, Vol 8 (2017)
Frontiers in Pharmacology

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, real-world, medicine.medical_treatment, Pazopanib, 03 medical and health sciences, 0302 clinical medicine, Renal cell carcinoma, Interquartile range, Internal medicine, medicine, pazopanib, Pharmacology (medical), Progression-free survival, Adverse effect, Original Research, Pharmacology, Everolimus, sequential therapy, business.industry, lcsh:RM1-950, Everolimus, Metastatic renal carcinoma, Pazopanib, Real-world, Sequential therapy, metastatic renal carcinoma, medicine.disease, everolimus, Nephrectomy, Discontinuation, Surgery, Everolimu, 030104 developmental biology, lcsh:Therapeutics. Pharmacology, 030220 oncology & carcinogenesis, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::218cc3d26bd98aec6dbe5ea084af4c61Test
http://journal.frontiersin.org/article/10.3389/fphar.2017.00484/fullTest

8

Whole-exome sequencing in radically resected gastric cancer (GC): Analysis of patients (pts) with poor prognostic factors from the Italian Trial of Adjuvant Chemotherapy Adenocarcinoma (ITACA-S) trial

مصطلحات موضوعية: Oncology, Cancer Research, Poor prognosis, medicine.medical_specialty, Adjuvant chemotherapy, business.industry, Cancer, medicine.disease, Primary tumor, Surgery, Internal medicine, medicine, Adenocarcinoma, business, Exome, Exome sequencing, Nodal involvement

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::652c19d4d87198bf93822dc194ef23c7Test
http://hdl.handle.net/11577/3254022Test

9

Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment

المؤلفون: Anna Capasso, Claudia Cardone, Maurizio Di Bisceglie, Michele Orditura, Stefania Napolitano, Evaristo Maiello, Anna Maria Rachiglio, Giulia Martini, Fortunato Ciardiello, Teresa Troiani, Alfonso Reginelli, Vincenzo Sforza, Nicola Normanno, Erika Martinelli, Anna Nappi, Fernando De Vita, Floriana Morgillo, Tiziana Latiano, Salvatore Cappabianca

المساهمون: Martinelli, Erika, Sforza, Vincenzo, Cardone, Claudia, Capasso, Anna, Nappi, Anna, Martini, Giulia, Napolitano, Stefania, Rachiglio, Anna Maria, Normanno, Nicola, Cappabianca, Salvatore, Reginelli, Alfonso, Bisceglie, Maurizio Di, Latiano, Tiziana Pia, Maiello, Evaristo, Orditura, Michele, Morgillo, Floriana, Ciardiello, Fortunato, Troiani, Teresa, De Vita, Fernando

المصدر: ESMO Open

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::505958790fee01b1614a2a36053e3e3eTest
http://hdl.handle.net/11591/384041Test

10

Emerging VEGF-receptor inhibitors for colorectal cancer

المؤلفون: Teresa Troiani, Fernando De Vita, Michele Orditura, Fortunato Ciardiello, Giulio Belli, Erika Martinelli, Floriana Morgillo

المساهمون: Martinelli, Erika, Troiani, Teresa, Morgillo, Floriana, Orditura, Michele, DE VITA, Ferdinando, Belli, G, Ciardiello, Fortunato

المصدر: Expert Opinion on Emerging Drugs. 18:25-37

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Bevacizumab, Pyridines, Colorectal cancer, Recombinant Fusion Proteins, medicine.medical_treatment, Angiogenesis Inhibitors, Antineoplastic Agents, Pharmacology, Antibodies, Monoclonal, Humanized, Targeted therapy, chemistry.chemical_compound, Regorafenib, Internal medicine, VEGF Signaling Pathway, medicine, Animals, Humans, Pharmacology (medical), Neoplasm Metastasis, Aflibercept, Clinical Trials as Topic, business.industry, Phenylurea Compounds, Drugs, Investigational, medicine.disease, digestive system diseases, Clinical trial, Receptors, Vascular Endothelial Growth Factor, chemistry, Monoclonal, Colorectal Neoplasms, business, Signal Transduction, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8793bdae651cf9622ac7ce694a80ff7cTest
https://doi.org/10.1517/14728214.2013.749856Test

تنقيح النتائج